
A Novel, Sustainable, and Gentle Cleansing Ingredient
Speaker
Dennis Abbeduto Business Manager - Colonial Chemical

Speaker
Dennis Abbeduto Business Manager - Colonial ChemicalSpeaker
Fanny Vocanson Sales Manager France & UK - LipoTrueK-Beauty has redefined beauty with its innovative textures, multifunctional products, and unique sensory experience. This presentation explores how these concepts can be adapted for the European market through practical formulation examples featuring Momentive's Harmonie™ ingredients and silicone technologies, delivering enhanced spreading, cushioning, and optical benefits while meeting local consumer preferences and trends.
Speaker
Olga Borisova Lead Field Marketing Engineer - Momentive
Introduction: Peptides are a cornerstone of anti-aging science, yet innovation typically prioritizes new sequences over delivery efficiency. This study addresses the inherent limitations of peptide stability and bioavailability by developing a novel lipid core-shell capsule for Pal-KTTKS. While Pal-KTTKS is a gold-standard anti-wrinkle agent, its efficacy is often hindered by poor skin penetration and rapid degradation. We present a sophisticated delivery strategy designed to maximize the therapeutic window of this peptide through structural stabilization and controlled release.
Methods: Lipid core-shell systems were synthesized using a blend of solid/liquid lipids stabilized by phospholipids. Stability was monitored at room temperature and 40°C via particle size (light diffraction) and pH. Structural characterization was performed using Small-Angle X-ray Scattering (SAXS) and TEM. Encapsulation efficiency was determined by tangential filtration, and release kinetics were analysed via dialysis. Ex vivo bioactivity was assessed in skin explants (with/without microneedling) via immunohistochemistry for collagen and involucrin. Finally, a double-blind, half-face clinical study (n=33) evaluated efficacy at 3 ppm over 28 days using fringe projection and identometry to measure skin topography and firmness.
Results: The system maintained stability for 12 months (0.27 ± 0.04 µm) with 99% encapsulation efficiency. SAXS confirmed a complex multilayered architecture (structural diameter 178 nm). Release profiles followed biexponential and Weibull models, showing a biphasic mechanism 37 times slower than free peptide, confirming the core-shell organization. Encapsulation extended the peptide half-life from 60 minutes to 20 hours, providing a robust barrier against enzymatic degradation. In skin explants, the system significantly increased involucrin and Collagen III, IV, and total collagen compared to free peptide; microneedling further synergized Collagen I/III synthesis. Clinically, the encapsulated form outperformed the free peptide, achieving a 10.4% reduction in microstructure density and a 25.0% increase in firmness (vs. 5.9% and 17.2% for free peptide). Visible smoothing was significant by day 14, with progressive improvement through day 28.
Conclusions: Nanostructured lipid encapsulation creates a protective, controlled-release environment for Pal-KTTKS. By extending enzymatic half-life and enhancing cutaneous efficacy, this system achieves superior clinical outcomes over traditional formulations. These results demonstrate that lipid encapsulation is a highly effective strategy for optimizing the delivery and performance of bioactive peptides.
Speaker
Carola Schwaiberger Business Development Specialist - Croda Europe LtdSpeaker
Stephan Telge International Technical Sales Manager - CLR Berlin
Julie Vernhes Principal Technical Specialist, EMEA - InolexWhat will consumers expect from personal care next?
From evolving skincare needs and changing daily routines to new expectations around long-term health and personal wellbeing, the personal care landscape is creating exciting opportunities for innovation.
Join Surfachem as we explore the consumer shifts shaping tomorrow's products, and discover how innovative ingredients and formulation expertise can translate emerging market opportunities into tangible ideas for 2027 and beyond.
Speakers
Harprit Kular Senior Technical Development Manager - Surfachem
Sabina Lawson Senior Account Manager - Surfachem
Collagen has always been one of the hero of anti-ageing skincare. As the most abundant structural protein in the skin, it is responsible for firmness, elasticity, resilience, and the skin’s natural renewal processes. However, ageing is not only associated with a decline in collagen production. Daily stressors such as UV exposure, pollution, oxidative stress, and glycation progressively damage collagen fibers, compromising the skin’s architecture.
NeoHelix™ Regenerate brings a new perspective to the collagen story by moving beyond traditional collagen-boosting approaches toward targeted collagen repair. Inspired by biomedical Collagen Hybridizing Peptide (CHP) technology, NeoHelix™ Regenerate is designed to selectively recognize and bind damaged collagen structures while leaving healthy collagen untouched. This precision-targeting mechanism helps the skin identify areas requiring renewal and supports its natural self-repair processes.
What makes NeoHelix™ Regenerate truly innovative is its focus on collagen reparation rather than simple collagen stimulation. By supporting collagen repair where damage exists, the peptide helps create a healthier environment for collagen I and III renewal, promotes skin regeneration, and protects the extracellular matrix from glycation-related damage. Clinical studies demonstrated a 41% reduction in damaged collagen, a 65% increase in hyaluronic acid levels, and a visible reduction in wrinkle appearance.
NeoHelix™ Regenerate: it doesn't just support collagen production. It helps skin recognize where collagen repair is most needed, opening a new era of precision collagen repair and next-generation skin rejuvenation.
Speaker
Monia Benvegnu Market Development Manager - BASF Beauty Care Solutions
Innospec’s gentle, high-performing surfactants bring endless possibilities, unlocking a world of textures and formats, from pastes to tablets, oral care to skin care.
Stop by Innospec’s display to discover our inspiring formulations and visit Stand 426 to connect with our experts and explore your next formulation breakthrough.
Speaker
Alice Miles Technical Manager - InnospecSpeaker
Valérie Guigues European Market & Key Accounts Manager - Stéarinerie Dubois
In this session, Derek Butler will show how multi-omic approaches can reveal the molecular blueprint of ageing and provide stronger evidence for longevity-focused products. By integrating host markers (such as ageing-related gene expression, protein and lipid profiles, and metabolomic signatures) with microbiome insights, multi-omics enables a deeper understanding of how products influence both immediate and long-term skin biology.
Through practical examples, the talk will demonstrate how multi-omic data can be aligned with clinical outcomes to validate mechanisms of action, measure product performance, and support credible, science-backed longevity claims.
Attendees will learn when to apply multi-omic study designs, what ageing pathways can be explored, and how molecular evidence can enhance the development and substantiation of next-generation cosmetic products.
Speaker
Derek Butler Commercial Director - Sequential